MILLER MICHAEL PATRICK
SEC Form 4 insider trading activity
MILLER MICHAEL PATRICK has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including PBYI, RIGL, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, MILLER MICHAEL PATRICK is listed as Director at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, MILLER MICHAEL PATRICK reported no open-market purchases and 1 open-market sale totaling $97K in PBYI.
Companies traded
Other insiders at PBYI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$97K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MILLER MICHAEL PATRICK made?
MILLER MICHAEL PATRICK has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including PBYI, RIGL since 2025.
Which companies does MILLER MICHAEL PATRICK trade?
MILLER MICHAEL PATRICK has filed SEC Form 4 disclosures for 2 companies, including PBYI, RIGL.
When was MILLER MICHAEL PATRICK's most recent SEC Form 4 filing?
MILLER MICHAEL PATRICK's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is MILLER MICHAEL PATRICK's total buy and sell value in the current window?
Inside the rolling retention window, MILLER MICHAEL PATRICK bought $0 and sold $97K based on SEC Form 4 filings.
What was MILLER MICHAEL PATRICK's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 PBYI shares on 2025-11-11, worth $97K, per SEC Form 4 filings.